HybriDetect Platform Development

About Milenia Biotec

Milenia Biotec is a private, commercial-stage diagnostics company focused on lateral flow assay (LFA) technology. Its core offering is the HybriDetect platform, a universal test strip and development kit that allows researchers and other companies to rapidly prototype and develop custom rapid tests for various targets, including molecular amplicons from techniques like LAMP and RPA. The company generates revenue through direct sales of its development kits and finished diagnostic tests, leverages a global distributor network, and operates in the growing point-of-care and rapid diagnostic testing market. Its strategy combines a platform/tool business with a pipeline of proprietary diagnostic assays.

Therapeutic Areas